Susquehanna International Group, LLP Puma Biotechnology, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$2.25 - $4.03 $28,350 - $50,778	12,600 New	12,600 $32,000
Q1 2024 May 07, 2024	SELL	$4.29 - $7.4 $24,024 - $41,440	-5,600 Reduced 29.02%	13,700 $72,000
Q4 2023 Feb 14, 2024	SELL	$2.23 - $4.49 $46,607 - $93,841	-20,900 Reduced 51.99%	19,300 $83,000
Q3 2023 Nov 14, 2023	BUY	$2.63 - $4.09 $18,410 - $28,630	7,000 Added 21.08%	40,200 $105,000
Q2 2023 Aug 11, 2023	SELL	$2.6 - $3.58 $7,540 - $10,382	-2,900 Reduced 8.03%	33,200 $117,000
Q1 2023 May 16, 2023	BUY	$2.21 - $4.82 $24,310 - $53,020	11,000 Added 43.82%	36,100 $111,000
Q4 2022 Feb 14, 2023	SELL	$2.12 - $5.08 $27,560 - $66,040	-13,000 Reduced 34.12%	25,100 $106,000
Q3 2022 Nov 14, 2022	SELL	$2.27 - $3.84 $36,320 - $61,440	-16,000 Reduced 29.57%	38,100 $90,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $123M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.